Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double-blind, placebo-controlled, randomized clinical trial
Author: Katz, L
de Amorim, MMR
Figueiroa, JN
Silva, JLPE
Abstract: OBJECTIVE: The purpose of this study was to determine the effectiveness of postpartum dexamethasone in patients with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. STUDY DESIGN: A prospective, randomized, double-blind trial was conducted in which 105 women with HELLP syndrome were enrolled and assigned randomly to treatment or placebo groups following delivery. Duration of hospital stay, maternal morbidity, and laboratory and clinical parameters were evaluated. RESULTS: There was no difference in maternal morbidity or mortality between the 2 groups. There was also no difference in duration of hospitalization and the need for rescue scheme or the use of blood products between groups. Linear model adjustments showed no significant difference between groups with respect to the pattern of platelet count recovery, aspartate aminotransferase, lactate dehydrogenase, hemoglobin, or diuresis. CONCLUSION: These findings do not support the use of dexamethasone in the puerperium for recovery of patients with HELLP syndrome.
Subject: dexamethasone
elevated liver enzymes
low platelets syndrome
randomized controlled trial
Country: EUA
Editor: Mosby-elsevier
Citation: American Journal Of Obstetrics And Gynecology. Mosby-elsevier, v. 198, n. 3, 2008.
Rights: fechado
Identifier DOI: 10.1016/j.ajog.2007.10.797
Date Issue: 2008
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000253730000014.pdf359.64 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.